Notably, there was a positive trend for OS in MATRix treated DLBCL-SCNSL patients who finally had received HDT-ASCT ( Suppl.
← all excerpts
Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.
1
—
—